MedPath

Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful?

Not Applicable
Conditions
Digestive System
Paediatrics
irritable bowel syndrome
Registration Number
PACTR201706002337124
Lead Sponsor
tanta university, faculty of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

adolescent diagnosed with IBS and vitamin D deficiency depending on ROME III criteria for diagnosis of childhood irritable bowel syndrome

Exclusion Criteria

children with recent use of antibiotics (4 weeks),
normal vitamin D level,
recent change in IBS therapy,
history of gut surgery or radiation,
celiac disease,
chronic drug therapy,
children with body mass index (BMI) of less than 18 or more than 25,
chronic disease such as renal failure or diabetes mellitus,
patients taking vitamin D supplementation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to assess IBS symptoms and severity score after treatment with vitamin D for 6 months.;to assess IBS symptoms and severity score after treatment with vitamin D for 6 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath